The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.
Time and money are two of the major roadblocks as the horse racing industry struggles to come to terms with medication, drug testing, and security, officials said March 4 during the joint annual meeting of Harness Tracks of America and the Thoroughbred Racing Associations.
Testing of post race samples for erythropoietin and darbepoietin antibodies will begin Nov. 1 in New York under an emergency rule approved Oct. 21 by the state's Racing and Wagering Board.
Most Popular Stories
- Aqueduct Cancels Racing for Saturday, Jan. 31
- Leave the Light On Off Derby Trail
- Is Ceftiofur Sodium an Effective Treatment for Placentitis?
- The Legacy of Gone West
- Withers Favorite El Kabeir Breezes at Belmont
- Honor Code, Top Billing Near 4YO Debuts
- KY Derby Winner Thunder Gulch Pensioned at 23
- 2014 New Mexico Champions Announced
- Texas Red Set for Super Return in San Vicente
- Turfway Increases Purses, Adds Race Per Week